Department of Health Sciences, University of Florence, Florence, Italy.
Directorate of Health Professions, Local Health Agency Cuneo 1, Cuneo, Italy.
Clin Interv Aging. 2024 Oct 30;19:1765-1772. doi: 10.2147/CIA.S480480. eCollection 2024.
Chronic diseases in older age are major sources of burden for healthcare systems. Compliance with medications is the key to treatment success for these patients, especially for frail individuals living in community settings. However, adherence to long-term medications in this population is not optimal, which leads to the need for frequent screening of compliance within large-scale public health surveys. In this context, a brief, simple and valid measure capturing medication adherence is not yet available. This study aims to develop and psychometrically test the Therapeutic Adherence Scale, a brief four-item tool that measures medication adherence in community-dwelling older adults affected by chronic diseases.
We conducted a three-phase process of instrument development, content validity assessment and psychometric testing.
Of the candidate nine items derived from a review of the literature, only four were deemed essential to capture intentional and nonintentional nonadherence. These items underwent structural validity, convergent and known-groups validity, and internal consistency on a sample of 269 participants (mean age = 7.91 years, SD = 7.26). Confirmatory factor analysis confirmed satisfactory fit indices (RMSEA = 0.000, CFI = 1.00, TLI = 1.00). Scores of the TAS were higher for those perceiving loneliness ( = 0.33, p < 0.001), those declaring memory loss in the last year ( = 0.29, p < 0.001), and those exhibiting worse mental quality of life ( = -0.15, p = 0.03) compared with the other groups. Cronbach's alpha and split-half reliability coefficients were acceptable, with values of 0.68 and 0.77, respectively.
The Therapeutic Adherence Scale is a brief, valid and reliable self-report measure of medication adherence that can be used in practice and research to screen patients living in community settings. This tool is also free to use, which contributes to advancing knowledge on the field of medication adherence of older adults affected by chronic diseases.
老年人的慢性病是医疗系统的主要负担来源。对于这些患者,特别是居住在社区环境中的体弱个体,药物治疗的成功关键是药物的依从性。然而,该人群对长期药物治疗的依从性并不理想,这导致需要在大规模公共卫生调查中频繁筛查依从性。在这种情况下,还没有一种简单、有效的简短药物依从性测量工具。本研究旨在开发和心理测量治疗依从性量表,这是一种用于测量受慢性病影响的社区居住老年人药物依从性的简短四项工具。
我们进行了仪器开发、内容有效性评估和心理测量测试的三个阶段的过程。
从文献回顾中得出的 9 个候选项目中,只有 4 个被认为是捕捉故意和非故意不依从的必要项目。这 4 个项目经过了结构有效性、收敛性和已知组有效性以及 269 名参与者样本的内部一致性测试(平均年龄 = 7.91 岁,SD = 7.26)。验证性因子分析证实了令人满意的拟合指数(RMSEA = 0.000,CFI = 1.00,TLI = 1.00)。与其他组相比,那些感到孤独的人的 TAS 评分更高(= 0.33,p < 0.001),那些在过去一年中报告记忆力下降的人(= 0.29,p < 0.001),以及那些表现出更差的精神生活质量的人(= -0.15,p = 0.03)。Cronbach's alpha 和半分可靠性系数是可以接受的,分别为 0.68 和 0.77。
治疗依从性量表是一种简短、有效、可靠的药物依从性自评量表,可用于实践和研究中,以筛查居住在社区环境中的患者。该工具是免费使用的,这有助于推进受慢性病影响的老年人药物依从性领域的知识。